patvann/followup-bupropion-initiation
Resources
Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant
Bupropion has been used as an antidepressant for over 20 years, though its licence for such use varies and it is typically a third- or fourth-line agent. It has a unique pharmacology, inhibiting the reuptake of noradrenaline and dopamine, potentially providing pharmacological augmentation to more common antidepressants such as selective serotonergic reuptake inhibitors (SSRIs).
View Resource Paper